Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Zika Virus Infection Among Pregnant Women in US
MMWR; ePub 2016 May 20; Li, Simeone, et al
The Centers for Disease Control and Prevention (CDC) reported that there were 157 and 122 pregnant women (symptomatic and asymptomatic) with laboratory evidence of possible Zika virus infection residing in the US states and US territories, respectively. Among the 157 pregnant women from US states and the District of Columbia monitored, 73 (49%) reported clinical symptoms consistent with Zika virus disease. Among these symptomatic pregnant women, 64 (88%) reported rash, 36 (49%) arthralgia, 37 (51%) fever, and 17 (23%) conjunctivitis.
This report launches a weekly reporting of pregnant women with laboratory evidence of possible Zika virus infection in the US state and territories and is intended to assist health care providers who counsel pregnant women and to help facilitate planning services for affected families.
Simeone RM, Shapiro-Mendoza CK, Meaney-Delman D, et al. Possible Zika virus infection among pregnant women—United States and territories, May 2016. [Published online ahead of print May 20, 2016]. MMWR Morb Mortal Wkly Rep. doi:http://dx.doi.org/10.15585/mmwr.mm6520e1.
This Week's Must Reads
Must Reads in Clinical Guidelines
ACOG: Chronic Hypertension in Pregnancy, Obstet Gynecol; ePub 2019 Jan; Vidaeff, et al
ACOG Guidelines: Pregestational Diabetes Mellitus, Obstet Gynecol; ePub 2018 Dec; ACOG, et al
Management of Early Pregnancy Loss, Obstet Gynecol; ePub 2018 Nov; ACOG
Prophylactic Antibiotic Use in Labor & Delivery, Obstet Gynecol; 2018 Sep; Coleman, et al
USPSTF on Screening for Cervical Cancer, JAMA; 2018 Aug 21; US Preventive Services Task Force